Progressive lysosomal membrane permeabilization induced by iron oxide nanoparticles drives hepatic cell autophagy and apoptosis
Iron oxide nanoparticles (IONs) are frequently used in various biomedical applications, in particular as magnetic resonance imaging contrast agents in liver imaging. Indeed, number of IONs have been withdrawn due to their poor clinical performance. Yet comprehensive understanding of their interactions with hepatocytes remains relatively limited. Here we investigated how iron oxide nanocubes (IO-cubes) and clusters of nanocubes (IO-clusters) affect distinct human hepatic cell lines. The viability of HepG2, Huh7 and Alexander cells was concentration-dependently decreased after exposure to either IO-cubes or IO-clusters. We found similar cytotoxicity levels in three cell lines triggered by both nanoparticle formulations. Our data indicate that different expression levels of Bcl-2 predispose cell death signaling mediated by nanoparticles. Both nanoparticles induced rather apoptosis than autophagy in HepG2. Contrary, IO-cubes and IO-clusters trigger distinct cell death signaling events in Alexander and Huh7 cells. Our data clarifies the mechanism by which cubic nanoparticles induce autophagic flux and the mechanism of subsequent toxicity. These findings imply that the cytotoxicity of ION-based contrast agents should be carefully considered, particularly in patients with liver diseases.
Citations by journals
1
|
|
Journal of Alloys and Compounds
|
Journal of Alloys and Compounds
1 publication, 5.26%
|
Nanomaterials
|
Nanomaterials
1 publication, 5.26%
|
Colloids and Surfaces A: Physicochemical and Engineering Aspects
|
Colloids and Surfaces A: Physicochemical and Engineering Aspects
1 publication, 5.26%
|
Pharmaceuticals
|
Pharmaceuticals
1 publication, 5.26%
|
Journal of Cluster Science
|
Journal of Cluster Science
1 publication, 5.26%
|
Drug Delivery and Translational Research
|
Drug Delivery and Translational Research
1 publication, 5.26%
|
Acta Biomaterialia
|
Acta Biomaterialia
1 publication, 5.26%
|
Advanced Drug Delivery Reviews
|
Advanced Drug Delivery Reviews
1 publication, 5.26%
|
Journal of Controlled Release
|
Journal of Controlled Release
1 publication, 5.26%
|
Journal of Cellular Biochemistry
|
Journal of Cellular Biochemistry
1 publication, 5.26%
|
ACS Biomaterials Science and Engineering
|
ACS Biomaterials Science and Engineering
1 publication, 5.26%
|
ACS Nano
|
ACS Nano
1 publication, 5.26%
|
ACS Applied Nano Materials
|
ACS Applied Nano Materials
1 publication, 5.26%
|
Bulletin of the Korean Chemical Society
|
Bulletin of the Korean Chemical Society
1 publication, 5.26%
|
Journal of Biochemical and Molecular Toxicology
|
Journal of Biochemical and Molecular Toxicology
1 publication, 5.26%
|
Nanoscale Advances
|
Nanoscale Advances
1 publication, 5.26%
|
Journal of Nanobiotechnology
|
Journal of Nanobiotechnology
1 publication, 5.26%
|
Nanomedicine
|
Nanomedicine
1 publication, 5.26%
|
1
|
Citations by publishers
1
2
3
4
5
|
|
Elsevier
|
Elsevier
5 publications, 26.32%
|
Springer Nature
|
Springer Nature
3 publications, 15.79%
|
Wiley
|
Wiley
3 publications, 15.79%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
3 publications, 15.79%
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
2 publications, 10.53%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
1 publication, 5.26%
|
Future Medicine
|
Future Medicine
1 publication, 5.26%
|
1
2
3
4
5
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.